D-0536-2025 Class III
FDA drug recall D-0536-2025 was initiated by Imprimis NJOF, LLC on Jul 9, 2025 and is designated Class III. Reason for recall: Sub-Potent Drug: Subpotent assay results during stability testing. Affected quantity: 2,890 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 30, 2025
- Initiation Date
- Jul 9, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,890 vials
Product description
Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-733-05.
Reason for recall
Sub-Potent Drug: Subpotent assay results during stability testing.
Distribution pattern
Nationwide in the USA
Code information
Lot: 25MAR032, Exp. 07/16/2025.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0536-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026